Table 3.
Multivariate regression analysis |
||||||
---|---|---|---|---|---|---|
Model 1 |
Model 2 |
Model 3 |
||||
OR (95% CI) | P | OR (95% CI) | p | OR (95% CI) | p | |
Diabetes | 1.11 (0.98–1.27) | 0.116 | 1.11 (0.98–1.27) | 0.111 | 1.11 (0.98–1.27) | 0.113 |
NYHA | 1.14 (0.99–1.31) | 0.055 | 1.13 (0.99–1.29) | 0.077 | 1.13 (0.99–1.30) | 0.073 |
GFR-EPI | 1.08 (0.93–1.27) | 0.311 | 1.07 (0.91–1.26) | 0.394 | 1.08 (0.93–1.27) | 0.319 |
NT-proBNPa | 1.12 (0.97–1.30) | 0.139 | 1.09 (0.94–1.28) | 0.240 | 1.15 (0.991–1.33) | 0.067 |
LVEF | 0.84 (0.73–0.96) | 0.013 | 0.85 (0.74–0.97) | 0.019 | 0.83 (0.72–0.96) | 0.011 |
TAPSE | 0.87 (0.77–0.99) | 0.045 | 0.86 (0.76–0.98) | 0.026 | 0.87 (0.76–0.99) | 0.042 |
PVC > 5 | 1.20 (1.05–1.38) | 0.007 | – | – | – | – |
RRI | 1.22 (1.04–1.44) | 0.018 | 1.206 (1.021–1.425) | 0.029 | 1.21 (1.02–1.42) | 0.030 |
PASP | – | – | 1.217 (1.059–1.398) | 0.006 | – | – |
TR | – | – | – | – | 1.16 (1.01–1.33) | 0.041 |
After log-transformation. For abbreviations see Table 1.